180 Life Sciences Corp. (ATNF) Financials
ATNF Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 5.0 million | 5.1 million |
2023-06-30 | 13.7 million | 7.0 million |
2023-03-31 | 14.9 million | 7.8 million |
2022-12-31 | 19.7 million | 8.3 million |
ATNF Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.8 million | 583994 |
2023-06-30 | -3.1 million | 551310 |
2023-03-31 | -3.9 million | 557421 |
2022-12-31 | -2.9 million | 630846 |
ATNF Net Income
No data available :(
ATNF Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 2.7 million | - | - |
2023-06-30 | 2.0 million | - | - |
2023-03-31 | 2.6 million | - | - |
2022-12-31 | 7.0 million | - | - |
ATNF Shares Outstanding
ATNF Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.1 million | 2.4 million | - |
2023-06-30 | - | 920904 | 2.8 million | - |
2023-03-31 | - | 794993 | 4.0 million | - |
2022-12-31 | - | 585690 | 5.1 million | - |
ATNF Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 32693 |
2023-06-30 | - | 28550 |
2023-03-31 | - | 21772 |
2022-12-31 | - | 37608 |
ATNF
Price: $2
52 week price:
Earnings Per Share: -269.80 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 344800
Market Capitalization: 1.6 million